Keywords: atherogenics, enters, deal, fujisawa, usa, collaborate, japan

AtheroGenics enters deal with Fujisawa

Article | 26 January 2004

Print This

AtheroGenics of the USA is to collaborate with Japan's Fujisawa to further develop its AGI-1096 as an oral treatment for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in